Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
Xi Liu, … , Sakari Kauppinen, Ethan Dmitrovsky
Xi Liu, … , Sakari Kauppinen, Ethan Dmitrovsky
Published March 8, 2010
Citation Information: J Clin Invest. 2010;120(4):1298-1309. https://doi.org/10.1172/JCI39566.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 3

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

  • Text
  • PDF
Abstract

MicroRNAs (miRNAs) regulate gene expression. It has been suggested that obtaining miRNA expression profiles can improve classification, diagnostic, and prognostic information in oncology. Here, we sought to comprehensively identify the miRNAs that are overexpressed in lung cancer by conducting miRNA microarray expression profiling on normal lung versus adjacent lung cancers from transgenic mice. We found that miR-136, miR-376a, and miR-31 were each prominently overexpressed in murine lung cancers. Real-time RT-PCR and in situ hybridization (ISH) assays confirmed these miRNA expression profiles in paired normal-malignant lung tissues from mice and humans. Engineered knockdown of miR-31, but not other highlighted miRNAs, substantially repressed lung cancer cell growth and tumorigenicity in a dose-dependent manner. Using a bioinformatics approach, we identified miR-31 target mRNAs and independently confirmed them as direct targets in human and mouse lung cancer cell lines. These targets included the tumor-suppressive genes large tumor suppressor 2 (LATS2) and PP2A regulatory subunit B alpha isoform (PPP2R2A), and expression of each was augmented by miR-31 knockdown. Their engineered repression antagonized miR-31–mediated growth inhibition. Notably, miR-31 and these target mRNAs were inversely expressed in mouse and human lung cancers, underscoring their biologic relevance. The clinical relevance of miR-31 expression was further independently and comprehensively validated using an array containing normal and malignant human lung tissues. Together, these findings revealed that miR-31 acts as an oncogenic miRNA (oncomir) in lung cancer by targeting specific tumor suppressors for repression.

Authors

Xi Liu, Lorenzo F. Sempere, Haoxu Ouyang, Vincent A. Memoli, Angeline S. Andrew, Yue Luo, Eugene Demidenko, Murray Korc, Wei Shi, Meir Preis, Konstantin H. Dragnev, Hua Li, James DiRenzo, Mads Bak, Sarah J. Freemantle, Sakari Kauppinen, Ethan Dmitrovsky

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Total
Citations: 3 2 4 7 4 15 5 14 20 12 27 25 18 25 13 10 1 205
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (205)

Title and authors Publication Year
CDK2 inhibition produces a persistent population of polyploid cancer cells with a survival advantage
Liliya Tyutyunyk-Massey, Zibo Chen, Xiuxia Liu, Masanori Kawakami, Adam Harned, Yeap Ng, Brian Luke, Samuel Okpechi, Blessing Ogunlade, Yair Alfaro, Roberto Weigert, Kedar Narayan, Xi Liu, Ethan Dmitrovsky
JCI insight 2025
The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential
Bartoszewska E, Misiąg P, Czapla M, Rakoczy K, Tomecka P, Filipski M, Wawrzyniak-Dzierżek E, Choromańska A
International Journal of Molecular Sciences 2025
Current Evidence Supporting the Role of miRNA as a Biomarker for Lung Cancer Diagnosis Through Exhaled Breath Condensate Collection: A Narrative Review
Ferrari PA, Salis CB, Macciò A
Life 2025
microRNAs in exhaled breath condensate for diagnosis of lung cancer in a resource-limited setting: a concise review.
Rai D, Pattnaik B, Bangaru S, Tak J, Kumari J, Verma U, Vadala R, Yadav G, Dhaliwal RS, Kumar S, Kumar R, Jain D, Luthra K, Chosdol K, Palanichamy JK, Khan MA, Surendranath A, Mittal S, Tiwari P, Hadda V, Madan K, Agrawal A, Guleria R, Mohan A
2024
Interaction of noncoding RNAs with hippo signaling pathway in cancer cells and cancer stem cells
Abedimanesh S, Safaralizadeh R, Jahanafrooz Z, Najafi S, Amini M, Nazarloo SS, Bahojb Mahdavi SZ, Baradaran B, Jebelli A, Mokhtarzadeh AA
Non-coding RNA Research 2024
Initial development and testing of an exhaled microRNA detection strategy for lung cancer case–control discrimination
Shi M, Han W, Loudig O, Shah CD, Dobkin JB, Keller S, Sadoughi A, Zhu C, Siegel RE, Fernandez MK, DeLaRosa L, Patel D, Desai A, Siddiqui T, Gombar S, Suh Y, Wang T, Hosgood HD, Pradhan K, Ye K, Spivack SD
Scientific Reports 2023
miR-31 ameliorates type 2 diabetic vascular damage through up-regulation of hypoxia-inducible factor-1α/vascular endothelial growth factor-A.
Fu Y, Du R, Wang Y, Yuan Y, Zhang Y, Wang C, Zhang X
Journal of Diabetes Investigation 2023
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.
Wei CH, Huang L, Kreh B, Liu X, Tyutyunyk-Massey L, Kawakami M, Chen Z, Shi M, Kozlov S, Chan KC, Andresson T, Carrington M, Vuligonda V, Sanders ME, Horowitz A, Hwu P, Peng W, Dmitrovsky E, Liu X
Scientific Reports 2023
CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells
Chen Z, Liu X, Kawakami M, Liu X, Baker A, Bhatawadekar A, Tyutyunyk-Massey L, Narayan K, Dmitrovsky E
Cancer biology & therapy 2023
Role of MicroRNA-31 (miR-31) in Breast Carcinoma Diagnosis and Prognosis
GHARIB AF, KHALIFA AS, EED EM, BANJER HJ, SHAMI AA, EL ASKARY A, ELSAWY WH
In vivo (Athens, Greece) 2022
Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer.
Chu J, Fang X, Sun Z, Gai L, Dai W, Li H, Yan X, Du J, Zhang L, Zhao L, Xu D, Yan S
Frontiers in Oncology 2022
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis.
Chen Z, Zheng L, Chen Y, Liu X, Kawakami M, Mustachio LM, Roszik J, Ferry-Galow KV, Parchment RE, Liu X, Andresson T, Duncan G, Kurie JM, Rodriguez-Canales J, Liu X, Dmitrovsky E
Cancer biology & therapy 2022
MicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients
Kahng DH, Kim GH, Park SJ, Kim S, Lee MW, Lee BE, I H
Journal of Korean Medical Science 2022
Small Nucleolar Derived RNAs as Regulators of Human Cancer
Coley AB, DeMeis JD, Chaudhary NY, Borchert GM
Biomedicines 2022
The spring-like effect of microRNA-31 in balancing inflammatory and regenerative responses in colitis
Qu J, Shao C, Ying Y, Wu Y, Liu W, Tian Y, Yin Z, Li X, Yu Z, Shuai J
Frontiers in microbiology 2022
MiR-196a-5p facilitates progression of estrogen-dependent endometrial cancer by regulating FOXO1.
Zhu Y, Tang Y, Fan Y, Wu D
Histology and histopathology 2022
miR-31 Displays Subtype Specificity in Lung Cancer
ML Davenport, JB Echols, AD Silva, JC Anderson, P Owens, C Yates, Q Wei, S Harada, DR Hurst, MD Edmonds
Cancer research 2021
YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
F Szulzewsky, EC Holland, V Vasioukhin
Developmental Biology 2021
The high expression of miR-31 in lung adenocarcinoma inhibits the malignancy of lung adenocarcinoma tumor stem cells
Xu R, Liu T, Zuo L, Guo D, Ye G, Jiang J, Yu X, Zhang S, Hou C
Biochemistry and Biophysics Reports 2021
MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer.
Park JL, Kim SK, Jeon S, Jung CK, Kim YS
Cancers 2021
A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers
M Kawakami, LM Mustachio, Y Chen, Z Chen, X Liu, CH Wei, J Roszik, AS Kittai, AV Danilov, X Zhang, B Fang, J Wang, JV Heymach, L Tyutyunyk-Massey, SJ Freemantle, JM Kurie, , E Dmitrovsky
Molecular cancer therapeutics 2020
Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas
E Dama, V Melocchi, F Mazzarelli, T Colangelo, R Cuttano, LD Candia, GM Ferretti, M Taurchini, P Graziano, F Bianchi
Non-Coding RNA 2020
MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer
XN Lai, J Li, LB Tang, WT Chen, L Zhang, LX Xiong
International journal of molecular sciences 2020
Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review
K Nijakowski, A Surdacka
International journal of molecular sciences 2020
Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future
G Reid, TG Johnson, N van Zandwijk
Frontiers in Oncology 2020
Tissue microRNAs in non-small cell lung cancer detected with a new kind of liquid bead array detection system
YY Zheng, Y Fei, Z Wang, Y Chen, C Qiu, FR Li
Journal of Translational Medicine 2020
Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer
X Jin, Y Guan, Z Zhang, H Wang
BMC Cancer 2020
MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions
AM ElKhouly, RA Youness, MZ Gad
Non-coding RNA Research 2020
Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer
C Kong, YX Yao, ZT Bing, BH Guo, L Huang, ZG Huang, YC Lai, I Ioshikhes
PLoS computational biology 2020
circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway
QS Peng, YN Cheng, WB Zhang, H Fan, QH Mao, P Xu
Cell Death and Disease 2020

miR-331-3p Inhibits Tumor Cell Proliferation, Metastasis, Invasion by Targeting MLLT10 in Non-Small Cell Lung Cancer


QQ Tian, J Xia, X Zhang, BQ Gao, W Wang
Cancer management and research 2020
Unravelling the Role of miR-20b-5p, CCNB1, HMGA2 and E2F7 in Development and Progression of Non-Small Cell Lung Cancer (NSCLC)
S Arora, P Singh, AH Rahmani, SA Almatroodi, R Dohare, MA Syed
Biology : open access journal 2020
Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice
H Yamashita, S Surapureddi, RC Kovi, S Bhusari, TV Ton, JL Li, KR Shockley, SD Peddada, KE Gerrish, CV Rider, MJ Hoenerhoff, RC Sills, AR Pandiri
Archives of Toxicology 2020
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth
, Y Lu, Z Chen, X Liu, W Hu, L Zheng, Y Chen, JM Kurie, M Shi, LM Mustachio, T Adresson, S Fox, J Roszik, M Kawakami, SJ Freemantle, E Dmitrovsky
Molecular cancer research : MCR 2020
MicroRNAs: Crucial Regulators of Stress
Roufayel R, Kadry S
2020
MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma
N García-Sancha, R Corchado-Cobos, J Pérez-Losada, J Cañueto
International journal of molecular sciences 2019
miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer
Z Lu, Q He, J Liang, W Li, Q Su, Z Chen, Q Wan, X Zhou, L Cao, J Sun, Y Wu, L Liu, X Wu, J Hou, K Lian, A Wang
Molecular Therapy — Nucleic Acids 2019
MiR-222-3p in Platelets Serves as a Distinguishing Marker for Early Recognition of Kawasaki Disease
B Wang, L Wang, F Cheng, H Lv, L Sun, D Wei, Y Pu, J Wu, Y Hou, B Wen, X Xu, W Yan
Frontiers in Pediatrics 2019
FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
HH Hsu, WW Kuo, HN Shih, SF Cheng, CK Yang, MC Chen, CC Tu, VP Viswanadha, PH Liao, CY Huang
Cancers 2019
Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
Q Wang, T Xu, Y Tong, J Wu, W Zhu, Z Lu, J Ying
Molecular Therapy — Nucleic Acids 2019
MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2
YH Lai, H Liu, WF Chiang, TW Chen, LJ Chu, JS Yu, SJ Chen, HC Chen, BC Tan
Theranostics 2018
Evidence for a radiation-responsive ‘p53 gateway’ contributing significantly to the radioresistance of lepidopteran insect cells
A Kumar, S Chandna
Scientific Reports 2018
Tissue and serum microRNA profile of oral squamous cell carcinoma patients
A Schneider, B Victoria, YN Lopez, W Suchorska, W Barczak, A Sobecka, W Golusinski, MM Masternak, P Golusinski
Scientific Reports 2018
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
M Kawakami, LM Mustachio, L Zheng, Y Chen, J Rodriguez-Canales, B Mino, JM Kurie, J Roszik, PA Villalobos, KL Thu, J Silvester, DW Cescon, II Wistuba, TW Mak, , E Dmitrovsky
Proceedings of the National Academy of Sciences 2018
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2
P Ma, K Ni, J Ke, W Zhang, Y Feng, Q Mao
Experimental biology and medicine (Maywood, N.J.) 2018
Modulation of oncogenic miRNA biogenesis using functionalized polyamines
C Staedel, TP Tran, J Giraud, F Darfeuille, AD Giorgio, NJ Tourasse, F Salin, P Uriac, M Duca
Scientific Reports 2018
Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
J Yue, D Lv, C Wang, L Li, Q Zhao, H Chen, L Xu
Oncogene 2018
MicroRNAs and their role in environmental chemical carcinogenesis
M Li, X Huo, CB Davuljigari, Q Dai, X Xu
Environmental Geochemistry and Health 2018
miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2
Z Mohamed, MK Hassan, S Okasha, T Mitamura, S Keshk, Y Konno, T Kato, SF EL-khamisy, Y Ohba, H Watari
Oncotarget 2018
MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1
W Liu, X Wan, Z Mu, F Li, L Wang, J Zhao, X Huang
Oncology Letters 2018
Is microRNA-31 a key regulator of breast tumorigenesis?
T Powrózek, T Małecka-Massalska
Journal of Thoracic Disease 2018
Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression
J Zhang, D Gao, H Zhang
Molecular medicine reports 2018
Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma
T He, K McColl, N Sakre, Y Chen, G Wildey, A Dowlati
Molecular Oncology 2018
Large tumor suppressor 2, LATS2, activates JNK in a kinase-independent mechanism through ASK1
L Rusnak, C Tang, Q Qi, X Mo, H Fu, J Wu
Journal of Molecular Cell Biology 2018
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
LM Mustachio, Y Lu, LJ Tafe, V Memoli, J Rodriguez-Canales, B Mino, PA Villalobos, I Wistuba, H Katayama, SM Hanash, J Roszik, M Kawakami, K Cho, JF Hancock, F Chinyengetere, S Hu, X Liu, SJ Freemantle, E Dmitrovsky
Molecular cancer research : MCR 2017
Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection
C Stenfeldt, J Arzt, G Smoliga, M LaRocco, J Gutkoska, P Lawrence
Virology Journal 2017
Expression of miR-23a by Apoptotic Regulators in Human Cancer: A Review
R Roufayel, S Kadry
Cancer biology & therapy 2017
The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection
HF Moffett, AN Cartwright, HJ Kim, J Godec, J Pyrdol, T Äijö, GJ Martinez, A Rao, J Lu, TR Golub, H Cantor, AH Sharpe, CD Novina, KW Wucherpfennig
Nature Immunology 2017
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
N Furth, Y Aylon
Cell Death and Differentiation 2017
Identification of aminosulfonylarylisoxazole as microRNA-31 regulators
K Im, J Song, YT Han, S Lee, S Kang, KW Hwang, H Min, KH Min, BB Yang
PloS one 2017
MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells
A Korourian, R Roudi, A Shariftabrizi, Z Madjd
Experimental biology and medicine (Maywood, N.J.) 2017
Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles
SY Sathipati, SY Ho
Scientific Reports 2017
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis
Y Yang, L Ding, Q Hu, J Xia, J Sun, X Wang, H Xiong, D Gurbani, L Li, Y Liu, A Liu
Molecular Cancer 2017
miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer
N Wang, Y Li, J Zhou
BioMed Research International 2017
MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists
C Lv, F Li, X Li, Y Tian, Y Zhang, X Sheng, Y Song, Q Meng, S Yuan, L Luan, T Andl, X Feng, B Jiao, M Xu, MV Plikus, X Dai, C Lengner, W Cui, F Ren, J Shuai, SE Millar, Z Yu
Nature Communications 2017
Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study
L Izquierdo, R Montalbo, M Ingelmo-Torres, C Mallofré, M Ramírez-Backhaus, J Rubio, AV der Heijden, E Schaafsma, A Lopez-Beltran, A Blanca, N Lawrentschuk, A Alcaraz, L Mengual
Oncotarget 2017
MicroRNA‑31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1
N Lin, Y Zhou, X Lian, Y Tu
Oncology Letters 2017
Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance
C Li, Y Yin, X Liu, X Xi, W Xue, Y Qu
Oncotarget 2017
Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
Y Gao, J Yi, K Zhang, F Bai, B Feng, R Wang, X Chu, L Chen, H Song
Journal of Experimental & Clinical Cancer Research 2017
MicroRNA-31 suppresses the self-renewal capability of α2δ1+ liver tumor-initiating cells by targeting ISL1
Y Zhang, W Zhao, H Han, S Li, D Chen, Z Zhang
Oncotarget 2017
MicroRNA-31 promotes arterial smooth muscle cell proliferation and migration by targeting mitofusin‑2 in arteriosclerosis obliterans of the lower extremitie
S Huang, Z Chen, W Wu, M Wang, R Wang, J Cui, W Li, S Wang
Experimental and therapeutic medicine 2017
LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer
S Matsui, N Kagara, C Mishima, Y Naoi, M Shimoda, A Shimomura, K Shimazu, S Kim, S Noguchi
Oncology Letters 2017
miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition
H Ren, Y Qi, X Yin, J Gao
OncoTargets and therapy 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
M Kawakami, LM Mustachio, J Rodriguez-Canales, B Mino, J Roszik, P Tong, J Wang, JJ Lee, JH Myung, JV Heymach, FM Johnson, S Hong, L Zheng, S Hu, PA Villalobos, C Behrens, I Wistuba, S Freemantle, , E Dmitrovsky
JNCI Journal of the National Cancer Institute 2017
Function and regulation of microRNA-31 in development and disease: miR-31 IN D EVELOPMENT AND D ISEASE
NA Stepicheva, JL Song
Molecular Reproduction and Development 2016
The roles of miRNAs as potential biomarkers in lung diseases
SD Alipoor, IM Adcock, J Garssen, E Mortaz, M Varahram, M Mirsaeidi, A Velayati
European Journal of Pharmacology 2016
MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer
C Caramés, I Cristobal, V Moreno, J Marín, P González-Alonso, B Torrejón, P Minguez, A Leon, J Martín, R Hernández, M Pedregal, M Martín, D Cortés, D García-Olmo, M Fernández, F Rojo, J García-Foncillas
International journal of molecular sciences 2016
Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D
T Zhang, Y Hu, J Ju, L Hou, Z Li, D Xiao, Y Li, J Yao, C Wang, Y Zhang, L Zhang
Scientific Reports 2016
miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression
W Hu, P Jin, C Ding, W Liu
Oncology Letters 2016
miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer
M Yan, X Li, D Tong, C Han, R Zhao, Y He, X Jin
Oncology reports 2016
Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1
OA Kent, JT Mendell, R Rottapel
Molecular cancer research : MCR 2016
Regulatory mechanisms of microRNAs in lung cancer stem cells
T Fan, W Wang, B Zhang, Y Xu, L Chen, S Pan, H Hu, Q Geng
SpringerPlus 2016
The ISG15-specific protease USP18 regulates stability of PTEN
LM Mustachio, M Kawakami, Y Lu, J Rodriguez-Canales, B Mino, C Behrens, I Wistuba, N Bota-Rabassedas, J Yu, JJ Lee, J Roszik, L Zheng, X Liu, SJ Freemantle, E Dmitrovsky
Oncotarget 2016
In Silico Study of miRNA Based Gene Regulation, Involved in Solid Cancer, by the Assistance of Argonaute Protein
SN Rath, D Das, VB Konkimalla, SK Pradhan
Genomics & Informatics 2016
Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2
H Wang, X Zhang, Y Liu, Z Ni, Y Lin, Z Duan, Y Shi, G Wang, F Li
Oncotarget 2016
BAP1 suppresses lung cancer progression and is inhibited by miR-31
Yu M, Liang H, Fu Z, Wang X, Liao Z, Zhou Y, Liu Y, Wang Y, Hong Y, Zhou X, Yan X, Yu M, Ma M, Zhang W, Guo B, Zhang J, Zen K, Zhang CY, Wang T, Zhang Q, Chen X
Oncotarget 2016
miR-31 initiates lung tumorigenesis and promotes mutant KRas-driven lung cancer
Mick Edmonds, Kelli L. Boyd, Tamara Moyo, Ramkrishna Mitra, Robert Duszynski, Maria Arrate, Xi Chen, Zhongming Zhao, Timothy Blackwell, Thomas andl, Christine Eischen
Journal of Clinical Investigation 2015
Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma
PN Valdmanis, B Roy-Chaudhuri, HK Kim, LC Sayles, Y Zheng, CH Chuang, DR Caswell, K Chu, Y Zhang, MM Winslow, EA Sweet-Cordero, MA Kay
Oncogene 2015
Advances in Experimental Medicine and Biology
G Santulli
Advances in experimental medicine and biology 2015
MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence
JH Cho, M Dimri, GP Dimri
The Journal of biological chemistry 2015
The Interplay between PP2A and microRNAs in Leukemia
PP Ruvolo
Frontiers in Oncology 2015
From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies
M Ciccone, GA Calin, D Perrotti
Frontiers in Oncology 2015
Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration
T Mikami, S Maruyama, T Abé, T Kobayashi, M Yamazaki, A Funayama, S Shingaki, T Kobayashi, C Jun, T Saku
Virchows Archiv 2015
SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells
RB Koumangoye, T Andl, KJ Taubenslag, ST Zilberman, CJ Taylor, HA Loomans, CD Andl
Molecular Cancer 2015
MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
JS Schaefer, T Attumi, AR Opekun, B Abraham, J Hou, H Shelby, DY Graham, C Streckfus, JR Klein
BMC Immunology 2015
Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence: miR-34a and Bladder Cancer Recurrence
AS Andrew, CJ Marsit, AR Schned, JD Seigne, KT Kelsey, JH Moore, L Perreard, MR Karagas, LF Sempere
International Journal of Cancer 2015
Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer
X Bian, Y Shen, G Zhang, C Gu, Y Cai, C Wang, Y Zhu, Y Zhu, H Zhang, B Dai, D Ye, AP Singh
PloS one 2015
Expression and Significance of Circulating MicroRNA-31 in Lung Cancer Patients
W Gu
Medical science monitor : international medical journal of experimental and clinical research 2015
Differentially Expressed MicroRNAs in Postpartum Breast Cancer in Hispanic Women
JL Muñoz-Rodríguez, L Vrba, BW Futscher, C Hu, IK Komenaka, MM Meza-Montenegro, LE Gutierrez-Millan, A Daneri-Navarro, PA Thompson, ME Martinez, DR Carter
PloS one 2015
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
T Higashi, H Hayashi, T Ishimoto, H Takeyama, T Kaida, K Arima, K Taki, K Sakamoto, H Kuroki, H Okabe, H Nitta, D Hashimoto, A Chikamoto, T Beppu, H Baba
British Journal of Cancer 2015
MicroRNA: master controllers of intracellular signaling pathways
PY Lui, DY Jin, NJ Stevenson
Cellular and Molecular Life Sciences 2015
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, C Behrens, H Kadara, ER Parra, JR Canales, J Zhang, U Giri, J Gudikote, MA Cortez, C Yang, Y Fan, M Peyton, L Girard, KR Coombes, C Toniatti, TP Heffernan, M Choi, GM Frampton, V Miller, JN Weinstein, RS Herbst, KK Wong, J Zhang, P Sharma, GB Mills, WK Hong, JD Minna, JP Allison, A Futreal, J Wang, II Wistuba, JV Heymach
Cancer Discovery 2015
Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo
C Taccioli, M Garofalo, H Chen, Y Jiang, GM Tagliazucchi, GD Leva, H Alder, P Fadda, J Middleton, KJ Smalley, T Selmi, S Naidu, JL Farber, CM Croce, LY Fong
JNCI Journal of the National Cancer Institute 2015
Effective Capture of Circulating Tumor Cells from a Transgenic Mouse Lung Cancer Model using Dendrimer Surfaces Immobilized with anti-EGFR
JH Myung, M Roengvoraphoj, KA Tam, T Ma, VA Memoli, E Dmitrovsky, SJ Freemantle, S Hong
Analytical Chemistry 2015
Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells
P Samuel, RC Pink, DP Caley, JM Currie, SA Brooks, DR Carter
Tumor Biology 2015
MicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targets
Glen Reid, Glen Reid
Journal of Thoracic Disease 2015
Evidence for microRNA-31 dependent Bim-Bax interaction preceding mitochondrial Bax translocation during radiation-induced apoptosis
A Kumar, S Ghosh, S Chandna
Scientific Reports 2015
microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance
S Naidu, M Garofalo
Frontiers in Medicine 2015
Role of deregulated microRNAs in non‑small cell lung cancer progression using fresh‑frozen and formalin‑fixed, paraffin‑embedded samples
Y Wang, J Chen, Z Lin, J Cao, H Huang, Y Jiang, H He, L Yang, N Ren, G Liu
Oncology Letters 2015
Micro-ribonucleic acid and carcinogenesis: breast cancer as an example
M Al-Khanbashi, M Al-Moundhri
Oncology Reviews 2015
HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
Liu P, Zhang H, Liang X, Ma H, Luan F, Wang B, Bai F, Gao L, Ma C
Oncotarget 2015
A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma
Zhang L, Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zhao XM
Oncotarget 2015
MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer
Kim HS, Lee KS, Bae HJ, Eun JW, Shen Q, Park SJ, Shin WC, Yang HD, Park M, Park WS, Kang YK, Nam SW
Oncotarget 2015
MicroRNA Profiles Discriminate among Colon Cancer Metastasis
A Drusco, GJ Nuovo, N Zanesi, GD Leva, F Pichiorri, S Volinia, C Fernandez, A Antenucci, S Costinean, A Bottoni, IA Rosito, CG Liu, A Burch, M Acunzo, Y Pekarsky, H Alder, A Ciardi, CM Croce, A Navarro
PloS one 2014
LUNG INJURY AND LUNG CANCER CAUSED BY CIGARETTE SMOKE-INDUCED OXIDATIVE STRESS: MOLECULAR MECHANISMS AND THERAPEUTIC OPPORTUNITIES INVOLVING THE CERAMIDE GENERATING MACHINERY AND EGF RECEPTOR
T Goldkorn, S Filosto, S Chung
Antioxidants & Redox Signaling 2014
MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1
H Wu, Q Liu, T Cai, Y Chen, F Liao, Z Wang
Diagnostic Pathology 2014
The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells
PP Ruvolo, VR Ruvolo, R Jacamo, JK Burks, Z Zeng, SR Duvvuri, L Zhou, Y Qiu, KR Coombes, N Zhang, SY Yoo, R Pan, N Hail, M Konopleva, G Calin, SM Kornblau, M Andreeff
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2014
Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas
SY Luo, KY Sit, AD Sihoe, WS Suen, WK Au, X Tang, ES Ma, WK Chan, II Wistuba, JD Minna, GS Tsao, DC Lam
Lung Cancer 2014
MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance
R Ottman, C Nguyen, R Lorch, R Chakrabarti
Molecular Cancer 2014
MicroRNAs-Role in Lung Cancer
M Guz, A Rivero-Müller, E Okoń, A Stenzel-Bembenek, K Polberg, M Słomka, A Stepulak
Disease Markers 2014
The new concepts on overcoming drug resistance in lung cancer
W Zhang, P Lei, X Dong, C Xu
Drug design, development and therapy 2014
The potential clinical applications and prospects of microRNAs in lung cancer
Y Gao, F Gao, JL Ma, WZ Sun, LP Song
OncoTargets and therapy 2014
An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma
X Li, Y Shi, Z Yin, X Xue, B Zhou
Journal of Translational Medicine 2014
microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
T Mitamura, H Watari, L Wang, H Kanno, M Kitagawa, MK Hassan, T Kimura, M Tanino, H Nishihara, S Tanaka, N Sakuragi
Molecular Cancer 2014
MiR-31 Dysregulation in Cystic Fibrosis Airways Contributes to Increased Pulmonary Cathepsin S Production
S Weldon, P McNally, DF McAuley, IK Oglesby, CL Wohlford-Lenane, JA Bartlett, CJ Scott, NG McElvaney, CM Greene, PB McCray, CC Taggart
American journal of respiratory and critical care medicine 2014
Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?
LF Sempere
Expert Review of Molecular Diagnostics 2014
Prognostic role of microRNA-31 in various cancers: a meta-analysis
S Wang, J Hu, D Zhang, J Li, Q Fei, Y Sun
Tumor Biology 2014
Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis
JH Pak, IK Kim, SM Kim, S Maeng, KJ Song, BK Na, TS Kim
Parasitology Research 2014
MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
X Feng, Y Wang, Z Ma, R Yang, S Liang, M Zhang, S Song, S Li, G Liu, D Fan, S Gao
BMC Cancer 2014
miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC
N Wang, H Liang, Y Zhou, C Wang, S Zhang, Y Pan, Y Wang, X Yan, J Zhang, CY Zhang, K Zen, D Li, X Chen
PloS one 2014
MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China
LF Xu, ZP Wu, Y Chen, QS Zhu, S Hamidi, R Navab
PloS one 2014
Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic
DE Carvajal-Hausdorf, KA Schalper, VM Neumeister, DL Rimm
Laboratory Investigation 2014
SATB1 and 2 in colorectal cancer
J Brocato, M Costa
Carcinogenesis 2014
Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component
S Matsumoto, K Nabeshima, M Hamasaki, T Shibuta, T Umemura
Medical Oncology 2014
MicroRNA in lung cancer
P Joshi
World Journal of Methodology 2014
EGF Up-Regulates miR-31 through the C/EBPβ Signal Cascade in Oral Carcinoma
WC Lu, SY Kao, CC Yang, HF Tu, CH Wu, KW Chang, SC Lin, B Mari
PloS one 2014
MicroRNAome genome: A treasure for cancer diagnosis and therapy: miRNA Knowledge for Clinicians
I Berindan-Neagoe, PC Monroig, B Pasculli, GA Calin
CA A Cancer Journal for Clinicians 2014
Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis.
Wang Y, Wang Q, Zhang N, Ma H, Gu Y, Tang H, Xu Z, Gao Y
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014
Cigarette Smoke Mediates Epigenetic Repression of miR-487b During Pulmonary Carcinogenesis
Sichuan Xi, Hong Xu, Jigui Shan, Yongguang Tao, Julie Hong, Suzanne Inchauste, Mary Zhang, Tricia Kunst, Leandro Mercedes, David Schrump
Journal of Clinical Investigation 2013
MiRNAs which target CD3 subunits could be potential biomarkers for cancers
FA Alashti, Z Minuchehr
PloS one 2013
Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties
T Bertero, I Bourget-Ponzio, A Puissant, A Loubat, B Mari, G Meneguzzi, P Auberger, P Barbry, G Ponzio, R Rezzonico
Cell cycle (Georgetown, Tex.) 2013
MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells
Z Zhong, Z Dong, L Yang, X Chen, Z Gong
Tumor Biology 2013
Overexpression of SNORD114-3 marks acute promyelocytic leukemia
T Liuksiala, KJ Teittinen, K Granberg, M Heinäniemi, M Annala, M Mäki, M Nykter, O Lohi
Leukemia 2013
Analysis of microRNAs expressions in chondrosarcoma: MicroRNA EXPRESSION PROFILING OF CHONDROSARCOMA
T Yoshitaka, A Kawai, S Miyaki, K Numoto, K Kikuta, T Ozaki, M Lotz, H Asahara
Journal of Orthopaedic Research 2013
PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer
S Xiong, Y Zheng, P Jiang, R Liu, X Liu, J Qian, J Gu, L Chang, D Ge, Y Chu
British Journal of Cancer 2013
Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2
MH Yang, J Yu, N Chen, XY Wang, XY Liu, S Wang, YQ Ding
PloS one 2013
MIR376A is a regulator of starvation-induced autophagy
G Korkmaz, KA Tekirdag, DG Ozturk, A Kosar, OU Sezerman, D Gozuacik
PloS one 2013
miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor
Y Yuan, Y Shen, L Xue, H Fan
PloS one 2013
Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling
A Hergovich
Cell & Bioscience 2013
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
S Cufí, R Bonavia, A Vazquez-Martin, C Oliveras-Ferraros, B Corominas-Faja, E Cuyàs, B Martin-Castillo, E Barrajón-Catalán, J Visa, A Segura-Carretero, J Joven, J Bosch-Barrera, V Micol, JA Menendez
Scientific Reports 2013
miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1
Y Ke, W Zhao, J Xiong, R Cao
Biochemistry Research International 2013
Evidence for tankyrases as antineoplastic targets in lung cancer
AM Busch, KC Johnson, RV Stan, A Sanglikar, Y Ahmed, E Dmitrovsky, SJ Freemantle
BMC Cancer 2013
MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1)
D Sun, F Yu, Y Ma, R Zhao, X Chen, J Zhu, CY Zhang, J Chen, J Zhang
The Journal of biological chemistry 2013
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer
T Ma, F Galimberti, CP Erkmen, V Memoli, F Chinyengetere, L Sempere, JH Beumer, BN Anyang, W Nugent, D Johnstone, GJ Tsongalis, JM Kurie, H Li, J Direnzo, Y Guo, SJ Freemantle, KH Dragnev, E Dmitrovsky
Molecular cancer therapeutics 2013
MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma
W Meng, Z Ye, R Cui, J Perry, V Dedousi-Huebner, A Huebner, Y Wang, B Li, S Volinia, H Nakanishi, T Kim, SS Suh, LW Ayers, P Ross, CM Croce, A Chakravarti, VX Jin, T Lautenschlaeger
Clinical cancer research 2013
Handbook of Experimental Pharmacology
T Goldkorn, S Chung, S Filosto
Handbook of experimental pharmacology 2013
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression
PC Lin, YL Chiu, S Banerjee, K Park, JM Mosquera, E Giannopoulou, P Alves, AK Tewari, MB Gerstein, H Beltran, AM Melnick, O Elemento, F Demichelis, MA Rubin
Cancer research 2012
MicroRNAs and lung cancers: from pathogenesis to clinical implications
J Qi, D Mu
Frontiers of Medicine 2012
The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma
HF Tu, CJ Liu, CL Chang, PW Wang, SY Kao, CC Yang, EH Yu, SC Lin, KW Chang
PloS one 2012
MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer
Y Lu, R Govindan, L Wang, P Liu, B Goodgame, W Wen, A Sezhiyan, J Pfeifer, Y Li, X Hua, Y Wang, P Yang, M You
Carcinogenesis 2012
Dicer-Dependent Biogenesis of Small RNAs Derived from 7SL RNA
YF Ren, G Li, J Wu, YF Xue, YJ Song, L Lv, XJ Zhang, KF Tang
PloS one 2012
miR-34 – a microRNA replacement therapy is headed to the clinic
AG Bader
Frontiers in Genetics 2012
A Unique Combination of Male Germ Cell miRNAs Coordinates Gonocyte Differentiation
SC McIver, SJ Stanger, DM Santarelli, SD Roman, B Nixon, EA McLaughlin
PloS one 2012
MicroRNAs – Important Molecules in Lung Cancer Research
P Leidinger, A Keller, E Meese
Frontiers in Genetics 2012
Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer
T Sasahira, M Kurihara, UK Bhawal, N Ueda, T Shimomoto, K Yamamoto, T Kirita, H Kuniyasu
British Journal of Cancer 2012
Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer
H Alder, C Taccioli, H Chen, Y Jiang, KJ Smalley, P Fadda, HG Ozer, K Huebner, JL Farber, CM Croce, LY Fong
Carcinogenesis 2012
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
L Benetatos, E Hatzimichael, E Londin, G Vartholomatos, P Loher, I Rigoutsos, E Briasoulis
Cellular and Molecular Life Sciences 2012
miRNA-Based Therapeutic Strategies
M Ishida, FM Selaru
Current Pathobiology Reports 2012
Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations
F Galimberti, AM Busch, F Chinyengetere, T Ma, D Sekula, VA Memoli, KH Dragnev, F Liu, KC Johnson, Y Guo, SJ Freemantle, AS Andrew, P Greninger, DJ Robbins, J Settleman, C Benes, E Dmitrovsky
International journal of oncology 2012
Evidence for the ubiquitin protease UBP43 as an antineoplastic target
Y Guo, F Chinyengetere, AV Dolinko, A Lopez-Aguiar, Y Lu, F Galimberti, T Ma, Q Feng, D Sekula, SJ Freemantle, AS Andrew, V Memoli, E Dmitrovsky
Molecular cancer therapeutics 2012
Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression
NP Singh, UP Singh, H Guan, P Nagarkatti, M Nagarkatti
PloS one 2012
Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease
M Girardot, J Cavaillé, R Feil
Epigenetics : official journal of the DNA Methylation Society 2012
Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7
Z Zhong, Z Dong, L Yang, X Chen, Z Gong
Experimental and therapeutic medicine 2012
Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma
S Yamanaka, NR Campbell, F An, SC Kuo, JJ Potter, E Mezey, A Maitra, FM Selaru
Cell cycle (Georgetown, Tex.) 2012
Role of MicroRNAs in lung disease
M Angulo, E Lecuona, JI Sznajder
Archivos de Bronconeumología 2012
miR-Sens--a retroviral dual-luciferase reporter to detect microRNA activity in primary cells
E Beillard, SC Ong, A Giannakakis, E Guccione, LA Vardy, PM Voorhoeve
RNA (New York, N.Y.) 2012
microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review)
YW Jiang, LA Chen
Molecular medicine reports 2012
MicroRNAs as Biomarkers for Clinical Features of Lung Cancer
R Hubaux
Journal of Postgenomics: Drug & Biomarker Development 2012
Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
L van der Weyden, A Papaspyropoulos, G Poulogiannis, AG Rust, M Rashid, DJ Adams, MJ Arends, E O'Neill
Cancer research 2012
miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer.
Zhong Z, Dong Z, Yang L, Gong Z
Journal of Cancer Research and Clinical Oncology 2012
Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.
Asangani IA, Harms PW, Dodson L, Pandhi M, Kunju LP, Maher CA, Fullen DR, Johnson TM, Giordano TJ, Palanisamy N, Chinnaiyan AM
Oncotarget 2012
Clinical Significance of MicroRNA Expression Profiles and Polymorphisms in Lung Cancer Development and Management
F Megiorni, A Pizzuti, L Frati
Pathology research international 2011
MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2
X Liu, Y Cheng, X Chen, J Yang, L Xu, C Zhang
The Journal of biological chemistry 2011
Regulation of cancer aggressive features in melanoma cells by microRNAs
E Greenberg, L Hershkovitz, O Itzhaki, S Hajdu, Y Nemlich, R Ortenberg, N Gefen, L Edry, S Modai, Y Keisari, MJ Besser, J Schachter, N Shomron, G Markel
PloS one 2011
A ten-microRNA expression signature predicts survival in glioblastoma
S Srinivasan, IR Patric, K Somasundaram
PloS one 2011
Characterisation and expression of microRNAs in developing wings of the neotropical butterfly Heliconius melpomene
AK Surridge, S Lopez-Gomollon, S Moxon, LS Maroja, T Rathjen, NJ Nadeau, T Dalmay, CD Jiggins
BMC Genomics 2011
RNA Interference and Cancer Therapy
Z Wang, DD Rao, N Senzer, J Nemunaitis
Pharmaceutical Research 2011
Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer
LF Sempere
Expert Review of Molecular Diagnostics 2011
Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity
P Ru, R Steele, EC Hsueh, RB Ray
Genes & cancer 2011
An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers
L Ma, Y Huang, W Zhu, S Zhou, J Zhou, F Zeng, X Liu, Y Zhang, J Yu
PloS one 2011
Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes
G Hanin, H Soreq
Frontiers in molecular neuroscience 2011
Involvement of MicroRNAs in Lung Cancer Biology and Therapy
X Liu, LF Sempere, Y Guo, M Korc, S Kauppinen, SJ Freemantle, E Dmitrovsky
Translational research : the journal of laboratory and clinical medicine 2011
Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study
Y Cheng, W Liu, ST Kim, J Sun, L Lu, J Sun, SL Zheng, WB Isaacs, J Xu
Cancer Genetics 2011
A microRNA downregulated in human cholangiocarcinoma controls cell cycle through multiple targets involved in the G1/S checkpoint
AV Olaru, G Ghiaur, S Yamanaka, D Luvsanjav, F An, I Popescu, S Alexandrescu, S Allen, TM Pawlik, M Torbenson, C Georgiades, LR Roberts, GJ Gores, A Ferguson-Smith, MI Almeida, GA Calin, E Mezey, FM Selaru
Hepatology 2011
Lung Injury and Cancer
T Goldkorn, S Filosto
American journal of respiratory cell and molecular biology 2010
Cyclin E Transgenic Mice: Discovery Tools for Lung Cancer Biology, Therapy, and Prevention: Fig. 1
SJ Freemantle, E Dmitrovsky
Cancer prevention research (Philadelphia, Pa.) 2010
MicroRNA in lung cancer
PY Lin, SL Yu, PC Yang
British Journal of Cancer 2010
Patterns of microRNA expression in non-human primate cells correlate with neoplastic development in vitro
B Teferedegne, H Murata, M Quiñones, K Peden, AM Lewis
PloS one 2010
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
OA Kent, RR Chivukula, M Mullendore, EA Wentzel, G Feldmann, KH Lee, S Liu, SD Leach, A Maitra, JT Mendell
Genes & development 2010
Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells
CJ Wang, J Stratmann, ZG Zhou, XF Sun
BMC Cancer 2010
Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells
S Xi, M Yang, Y Tao, H Xu, J Shan, S Inchauste, M Zhang, L Mercedes, JA Hong, M Rao, DS Schrump
PloS one 2010
The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1
Y Aylon, Y Ofir-Rosenfeld, N Yabuta, E Lapi, H Nojima, X Lu, M Oren
Genes & development 2010
Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors
LF Sempere, M Preis, T Yezefski, H Ouyang, AA Suriawinata, A Silahtaroglu, JR Conejo-Garcia, S Kauppinen, W Wells, M Korc
Clinical cancer research 2010
[MicroRNAs as therapeutic targets for lung cancer]
William C S CHO
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
146 readers on Mendeley
See more details